Will health insurance cover Inotersen?
Inotersen is a medication that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of a rare genetic disease called hereditary transthyretin (hATTR) amyloidosis. This condition affects the nervous system, causing a range of symptoms, including loss of sensation, muscle weakness, and organ damage. Given the high cost of this...
Inotersen is a medication that has been approved by the U.S....